Order Article Reprints

Pazgan-Simon M, Jaroszewicz J, Simon K, Lorenc B, Sitko M, Zarębska-Michaluk D, Dybowska D, Tudrujek-Zdunek M, Berak H, Mazur W, et al. Real-World Effectiveness and Safety of Direct-Acting Antivirals in Patients with Chronic Hepatitis C and Epilepsy: An Epi-Ter-2 Study in Poland. Journal of Personalized Medicine. 2023; 13(7):1111. https://doi.org/10.3390/jpm13071111

Pazgan-Simon, Monika, Jerzy Jaroszewicz, Krzysztof Simon, Beata Lorenc, Marek Sitko, Dorota Zarębska-Michaluk, Dorota Dybowska, Magdalena Tudrujek-Zdunek, Hanna Berak, Włodzimierz Mazur, and et al. 2023. "Real-World Effectiveness and Safety of Direct-Acting Antivirals in Patients with Chronic Hepatitis C and Epilepsy: An Epi-Ter-2 Study in Poland" Journal of Personalized Medicine 13, no. 7: 1111. https://doi.org/10.3390/jpm13071111

Pazgan-Simon, M., Jaroszewicz, J., Simon, K., Lorenc, B., Sitko, M., Zarębska-Michaluk, D., Dybowska, D., Tudrujek-Zdunek, M., Berak, H., Mazur, W., Klapaczyński, J., Janczewska, E., Parfieniuk-Kowerda, A., & Flisiak, R. (2023). Real-World Effectiveness and Safety of Direct-Acting Antivirals in Patients with Chronic Hepatitis C and Epilepsy: An Epi-Ter-2 Study in Poland. Journal of Personalized Medicine, 13(7), 1111. https://doi.org/10.3390/jpm13071111